Find therapies in clinical trials near you – page 139

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis

Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

Study on Colchicine for Patients with Acute Heart Failure

Study on Colchicine for Patients with Acute Heart Failure

Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Study on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Study on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Study on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy

Study on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy